Baillie Gifford - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 204 filers reported holding BEAM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$21,061,716
+25.9%
875,747
+67.2%
0.02%
+35.7%
Q2 2023$16,722,794
+20.6%
523,733
+15.7%
0.01%
+7.7%
Q1 2023$13,863,542
-22.1%
452,761
-0.5%
0.01%
-31.6%
Q4 2022$17,788,324
-3.1%
454,828
+18.1%
0.02%0.0%
Q3 2022$18,351,000
+4343.3%
385,218
+3509.3%
0.02%
Q2 2022$413,000
-32.5%
10,6730.0%0.00%
Q1 2022$612,000
-28.1%
10,6730.0%0.00%
Q4 2021$851,000
-8.6%
10,673
-0.3%
0.00%
Q3 2021$931,000
+1377.8%
10,700
+2097.1%
0.00%
Q2 2021$63,000
+50.0%
487
-6.2%
0.00%
Q1 2021$42,000
+5.0%
519
+4.8%
0.00%
Q4 2020$40,0004950.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
MWG Management Ltd. 2,346,934$56,443,76354.70%
HSG Holding Ltd 796,089$19,145,9402.05%
Redmile Group, LLC 1,469,725$35,346,8861.68%
ARK Investment Management 8,783,891$211,252,5901.62%
Casdin Capital, LLC 570,000$13,708,5001.52%
Deep Track Capital, LP 1,015,641$24,426,1660.94%
Yiheng Capital Management, L.P. 560,500$13,480,0250.69%
Temasek Holdings (Private) Ltd 4,317,789$103,842,8250.62%
FARALLON CAPITAL MANAGEMENT LLC 4,481,839$107,788,2280.54%
Alphabet Inc. 321,604$7,734,5760.50%
View complete list of BEAM THERAPEUTICS INC shareholders